Pfizer to stop research for Alzheimer's, Parkinson's drugs
Pfizer to stop research for Alzheimer's, Parkinson's drugs
Pharmaceutical giant says it plans to reallocate spending to areas where scientific expertise is strongest, expects 300 jobs will be cut from neuroscience units in Massachusetts and Connecticut.
